StonvexLoading…
StonvexStonvexStonvexCore line items from FHTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.27M | $30.91M | $21.66M | $13.51M |
Operating Income | $-21.57M | $-86.39M | $-62.51M | $-44.01M |
Net Income | $-19.88M | $-74.28M | $-52.62M | $-17.94M |
EPS (Diluted) | $-0.29 | $-1.18 | $-0.84 | $-0.58 |
Total Assets | $222.17M | $198.10M | $204.96M | $226.24M |
Total Liabilities | $298.57M | $306.60M | $294.62M | $302.89M |
Cash & Equivalents | $87.66M | $80.88M | $89.33M | $72.57M |
Free Cash Flow OCF − CapEx | $-25.27M | $-86.15M | $-63.88M | $-45.02M |
Shares Outstanding | 58.71M | 56.66M | 56.54M | 55.80M |